(Circulation. 2007;116:2520-2522.)
© 2007 American Heart Association, Inc.
Editorial |
From the Departments of Pediatrics and Genetics, Washington University School of Medicine, St Louis, Mo.
Correspondence to Patrick Y. Jay, MD, PhD, Departments of Pediatrics and Genetics, Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO 63110. E-mail jay_p{at}kids.wustl.edu
Key Words: Editorials conduction genetics Wolff-Parkinson-White syndrome heart block
In 1906, Tawara published his treatise, recently translated from German to English,1 on the anatomy of the cardiac conduction system, which he elucidated through painstaking dissection and histological examination. In the following decades, the conduction system was generally understood and studied in anatomic and physiological terms. Most molecular biology focused on the genes and proteins that generate or propagate the cardiac action potential. Unlike other tissues and organs, including the heart, little was known about its embryonic development, even though the anatomic form of the conduction system is clearly relevant to its function. Until recently, developmental biology was hampered by the lack of a working model of how the conduction system forms, reagents, and methods. This situation has changed significantly since Gourdie and Mikawa2 reported their seminal observations in 1995. In an elegant series of chick embryo experiments, their laboratories proved that a developing node or fiber in the central and peripheral conduction systems forms by recruitment of adjacent multipotent myocytes.2,3 The murine conduction system develops by the same process of accretion.4 Soon afterward, Berul et al,5 Morley et al,6 and Baker et al7 described their applications of intracardiac electrophysiology and optical mapping to study normal and abnormal conduction in the mouse, thus opening the door for experimental genetics and developmental biology.
Article p 2535
The inductive patterning of tissues is a central theme in development. In the chick embryo, endothelin-1 is secreted by the coronary arterioles to induce adjacent ventricular myocytes to become Purkinje cells.8,9 This particular pathway probably does not operate in the mouse. Some in vitro evidence suggests that neuregulin-1 plays a similar role,10 but no in vivo signaling pathway has been demonstrated to regulate the development of the mammalian central conduction system until now. Thus, the demonstration of a role for bone morphogenetic protein (BMP) signaling in the development of the atrioventricular (AV) conduction system by Stroud and colleagues11 is an important step forward.
BMPs, so named because they were originally discovered for their ability to induce bone formation,12 have far-reaching roles in the development of perhaps every organ and tissue in the body. BMP2 and BMP4 are expressed circumferentially around the embryonic AV canal myocardium and have well-described functions in patterning chamber septation and valve formation.13,14 Stroud et al11 show that conditional deletion of the cognate receptor Bmpr1a in the AV canal myocardium leads to pleiotropic conduction phenotypes that range from ventricular preexcitation to first-degree AV block. These physiological abnormalities were correlated with histopathological evidence for accessory AV pathways and morphologically abnormal AV nodes.
The authors classified the conduction defects that the conditional Bmpr1a knockout animals had into 4 groups: (1) normal, (2) intermittent preexcitation with normal AV node function, (3) predominant bypass conduction with AV node dysfunction, and (4) severe AV node dysfunction without an accessory pathway. It seems paradoxical that deletion of 1 gene could lead to a short, normal, or long PR interval, but contrasting phenotypes have likewise been described in the developing limb bud. BMP signaling regulates the number of digits formed. Mutations in the BMP pathway can result in extra or no digits, depending on the level of BMP signaling, developmental stage, or context within a prepatterned field.15
BMP2 and BMP4 probably also pattern the myocardium in ways that depend on the local milieu. In the early embryonic heart tube, the atrium and ventricle are in electrical continuity around the entire circumference of the AV canal. Electrical coupling between all the myocytes in the canal must ultimately be disrupted, except at the future His bundle. The annulus fibrosus simultaneously forms to insulate the atrial from the ventricular myocardium.16,17 In addition, some myocytes at the inner curvature of the looping heart tube are specified to become the AV node.18 One can reasonably hypothesize that BMP signaling regulates each of these processes in combination with other developmental inputs. As the phenotypes observed in the Bmpr1a mutant animals suggest, derangement of BMP signaling could lead to the persistence of accessory AV pathways, discontinuity of the His bundle, exuberant fibrosus that disrupts the architecture of the central conduction system, or abnormal patterning of the AV node. The identification of the other cues that are integrated with BMP signaling is of obvious interest.
In this regard, several transcription factors are known to be expressed preferentially in the conduction system, and mutations of some of them cause conduction defects. For example, the cardiac transcription factor Nkx2-5 is more highly expressed in the developing conduction system than surrounding contractile myocytes,19 and Nkx2-5 mutations are associated with AV node dysfunction.20,21 A null mutation of Nkx2-5 causes the AV node not to form. Haploinsufficiency causes hypocellularity of the central and peripheral conduction systems and absence of the proximal subdomain of the AV node.20 In another example, a heterozygous knockout of Tbx5, the transcription factor mutated in Holt-Oram syndrome, causes PR prolongation and patterning defects of the left and right bundle branches.22 Nkx2-5 and Tbx5 in concert with another transcription factor, Id2, coordinate the development of the Purkinje system.23 As in the limb bud, the cellular context on which BMP signaling acts may direct a myocyte to become a slow nodal cell, a fast-conducting His cell, or entirely uncoupled from its neighbor.
Interestingly, the parallel with the limb bud may extend to other genes besides BMPs and Tbx5. Tbx3 and Msx2, both transcription factors whose expression is regulated by BMP signaling in the limb bud, are respectively expressed in the conduction system and AV canal myocardium.24,25 Atrial expression of Tbx3 causes ectopic pacemaker activity consistent with its role in sinus node development; a loss-of-function phenotype has not been reported yet.26 Msx2 knockout mice do not appear to have a conduction phenotype or accessory AV pathways,27 but a low incidence of 1 of the classes of conduction defects described for the conditional Bmpr1a knockout could have escaped detection.
The demonstration of a role for BMP signaling in conduction system development provides an important foothold to elucidate the genetic basis of wiring the heart. Several transcription factors have been implicated in the development of the AV conduction system, and future investigation that builds on a wealth of knowledge about BMP signaling will undoubtedly help to draw the whole picture. Much effort in recent years has focused on turning stem or other pluripotent cells into contractile myocardium, but significant technical challenges remain. In contrast, one can envision a more modest goal. Armed with a genetic wiring diagram, a future interventional molecular cardiologist could manipulate a stem cell into a cardiac myocyte that expresses the entire repertoire of genes necessary for any 1 of several electrophysiological phenotypes. One could use these cells to build a bioartificial sinus or AV node or His bundle and then implant them into patients whose native pacemaker or conduction system had failed. A century later, Dr Tawara would no doubt be proud of what possibilities his work enabled.
| Acknowledgments |
|---|
Dr Jay is a Scholar of the Child Health Research Center of Excellence in Developmental Biology at Washington University School of Medicine (NIH K12-HD001487). Research is supported by the American Heart Association, Edward Mallinckrodt Jr. Foundation, Hartwell Foundation, and March of Dimes.
Disclosures
None.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Gourdie RG, Mima T, Thompson RP, Mikawa T. Terminal diversification of the myocyte lineage generates Purkinje fibers of the cardiac conduction system. Development. 1995; 121: 1423–1431.[Abstract]
3. Cheng G, Litchenberg WH, Cole GJ, Mikawa T, Thompson RP, Gourdie RG. Development of the cardiac conduction system involves recruitment within a multipotent cardiomyogenic lineage. Development. 1999; 126: 5041–5049.[Abstract]
4. Sedmera D, Reckova M, DeAlmeida A, Coppen SR, Kubalak SW, Gourdie RG, Thompson RP. Spatiotemporal pattern of commitment to slowed proliferation in the embryonic mouse heart indicates progressive differentiation of the cardiac conduction system. Anat Rec. 2003; 274A: 773–777.[Medline] [Order article via Infotrieve]
5. Berul CI, Aronovitz MJ, Wang PJ, Mendelsohn ME. In vivo cardiac electrophysiology studies in the mouse. Circulation. 1996; 94: 2641–2648.
6. Morley GE, Vaidya D, Samie FH, Lo C, Delmar M, Jalife J. Characterization of conduction in the ventricles of normal and heterozygous Cx43 knockout mice using optical mapping. J Cardiovasc Electrophysiol. 1999; 10: 1361–1375.[Medline] [Order article via Infotrieve]
7. Baker LC, London B, Choi BR, Koren G, Salama G. Enhanced dispersion of repolarization and refractoriness in transgenic mouse hearts promotes reentrant ventricular tachycardia. Circ Res. 2000; 86: 396–407.
8. Hyer J, Johansen M, Prasad A, Wessels A, Kirby ML, Gourdie RG, Mikawa T. Induction of Purkinje fiber differentiation by coronary arterialization. Proc Natl Acad Sci U S A. 1999; 96: 13214–13218.
9. Takebayashi-Suzuki K, Yanagisawa M, Gourdie RG, Kanzawa N, Mikawa T. In vivo induction of cardiac Purkinje fiber differentiation by coexpression of preproendothelin-1 and endothelin converting enzyme-1. Development. 2000; 127: 3523–3532.[Abstract]
10. Rentschler S, Zander J, Meyers K, France D, Levine R, Porter G, Rivkees SA, Morley GE, Fishman GI. Neuregulin-1 promotes formation of the murine cardiac conduction system. Proc Natl Acad Sci U S A. 2002; 99: 10464–10469.
11. Stroud DM, Gaussin V, Burch JBE, Yu C, Mishina Y, Schneider MD, Fishman GI, Morley GE. Abnormal conduction and morphology in the atrioventricular node of mice with atrioventricular canal–targeted deletion of Alk3/Bmpr1a receptor. Circulation. 2007; 116: 2535–2543.
12. Urist MR. Bone: formation by autoinduction. Science. 1965; 150: 893–899.
13. Jiao K, Kulessa H, Tompkins K, Zhou Y, Batts L, Baldwin HS, Hogan BL. An essential role of Bmp4 in the atrioventricular septation of the mouse heart. Genes Dev. 2003; 17: 2362–2367.
14. Ma L, Lu MF, Schwartz RJ, Martin JF. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development. 2005; 132: 5601–5611.
15. Robert B. Bone morphogenetic protein signaling in limb outgrowth and patterning. Dev Growth Differ. 2007; 49: 455–468.[Medline] [Order article via Infotrieve]
16. Arguello C, Alanis J, Pantoja O, Valenzuela B. Electrophysiological and ultrastructural study of the atrioventricular canal during the development of the chick embryo. J Mol Cell Cardiol. 1986; 18: 499–510.[CrossRef][Medline] [Order article via Infotrieve]
17. Arrechedera H, Strauss M, Arguello C, Ayesta C, Anselmi G. Ultrastructural study of the myocardial wall of the atrio-ventricular canal during the development of the embryonic chick heart. J Mol Cell Cardiol. 1984; 16: 885–895.[CrossRef][Medline] [Order article via Infotrieve]
18. Viragh S, Challice CE. The development of the conduction system in the mouse embryo heart, II: histogenesis of the atrioventricular node and bundle. Dev Biol. 1977; 56: 397–411.[CrossRef][Medline] [Order article via Infotrieve]
19. Thomas PS, Kasahara H, Edmonson AM, Izumo S, Yacoub MH, Barton PJ, Gourdie RG. Elevated expression of Nkx-2.5 in developing myocardial conduction cells. Anat Rec. 2001; 263: 307–313.[CrossRef][Medline] [Order article via Infotrieve]
20. Jay PY, Harris BS, Maguire CT, Buerger A, Wakimoto H, Tanaka M, Kupershmidt S, Roden DM, Schultheiss TM, OBrien TX, Gourdie RG, Berul CI, Izumo S. Nkx2-5 mutation causes anatomic hypoplasia of the cardiac conduction system. J Clin Invest. 2004; 113: 1130–1137.[CrossRef][Medline] [Order article via Infotrieve]
21. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP, Maron BJ, Seidman CE, Seidman JG. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science. 1998; 281: 108–111.
22. Moskowitz IP, Pizard A, Patel VV, Bruneau BG, Kim JB, Kupershmidt S, Roden D, Berul CI, Seidman CE, Seidman JG. The T-box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction system. Development. 2004; 131: 4107–4116.
23. Moskowitz IP, Kim JB, Moore ML, Wolf CM, Peterson MA, Shendure J, Nobrega MA, Yokota Y, Berul C, Izumo S, Seidman JG, Seidman CE. A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell. 2007; 129: 1365–1376.[CrossRef][Medline] [Order article via Infotrieve]
24. Abdelwahid E, Rice D, Pelliniemi LJ, Jokinen E. Overlapping and differential localization of Bmp-2, Bmp-4, Msx-2 and apoptosis in the endocardial cushion and adjacent tissues of the developing mouse heart. Cell Tissue Res. 2001; 305: 67–78.[CrossRef][Medline] [Order article via Infotrieve]
25. Hoogaars WM, Tessari A, Moorman AF, de Boer PA, Hagoort J, Soufan AT, Campione M, Christoffels VM. The transcriptional repressor Tbx3 delineates the developing central conduction system of the heart. Cardiovasc Res. 2004; 62: 489–499.
26. Hoogaars WM, Engel A, Brons JF, Verkerk AO, de Lange FJ, Wong LY, Bakker ML, Clout DE, Wakker V, Barnett P, Ravesloot JH, Moorman AF, Verheijck EE, Christoffels VM. Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. Genes Dev. 2007; 21: 1098–1112.
27. Jay PY, Maguire CT, Wakimoto H, Izumo S, Berul CI. Absence of Msx2 does not affect cardiac conduction or rescue conduction defects associated with Nkx2-5 mutation. J Cardiovasc Electrophysiol. 2005; 16: 82–85.[Medline] [Order article via Infotrieve]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |